Paydirt
RB
Insider

Rahul D. Ballal

Director

Rahul D. Ballal (Director) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales), most often in Agios Pharmaceuticals, Inc. (AGIO). The largest single filing was $1.0M of AGIO (18,500 sh across 4 lots, as filed), executed Nov 7 2024.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.3M
shares × price, as filed
Last traded
Nov 8 2024
Filed Nov 12 2024

Median ADV $39.7M across their filed names

Open performance
Volume by month
$1.0M$514K$0Oct 2024Apr 2025Oct 2025Apr 2026Oct 2024 · sells $294KNov 2024 · sells $1.0M
Buys $0 Sells $1.3M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 2 filings

Sector per market data · by filing · past 24 months

Most traded names
AGIO Agios Pharmaceuticals, Inc. AGIO · 0 buys · 1 sell 1 filing ELVN Enliven Therapeutics, Inc. ELVN · 0 buys · 1 sell 1 filing
Recent filings
AGIOSALE Agios Pharmaceuticals, Inc. View filing → $1.0M
18,500 sh across 4 lots
Exec Nov 7 2024
Filed Nov 12 2024 · 5:30 PM ET
ELVNSALE Enliven Therapeutics, Inc. View filing → $294K
10,420 sh × $28.17
Exec Oct 8 2024
Filed Oct 10 2024 · 5:30 PM ET